ABAmanda R. van Buul

Amanda R. van Buul

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda R. van Buul has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Factors associated with physical activity among COPD patients with mild or moderate airflow obstruction

    by Amanda R. van Buul, Marise J. Kasteleyn, Vitalii Poberezhets, Tobias N. Bonten, Renée De Mutsert, Pieter S. Hiemstra, Saskia le Cessie, Frits R. Rosendaal, Niels H. Chavannes, Christian Taube

    Physical inactivity is already present among patients with chronic obstructive pulmonary disease (COPD) of mild or moderate airflow obstruction. Most previous studies that reported on determinants of physical activity in COPD included patients with severe COPD. Therefore, the aim of this study was to explore which patient characteristics were related with physical activity in COPD patients with mild or moderate airflow obstruction. Cross-sectional analyses were performed on patients selected from the population-based Netherlands Epidemiology of Obesity study. Patients were included if they had a physician-diagnosed COPD GOLD 0-2 or had newly diagnosed COPD GOLD 1-2. Physical activity was evaluated using the Short Questionnaire to Assess Health-Enhancing Physical Activity (SQUASH) questionnaire and reported in hours per week of metabolic equivalents (MET-h/week). Associations between sociodemographic, lifestyle, clinical and functional characteristics were examined using regression analysis. 323 patients were included in research (77 with physician-diagnosed and 246 with newly diagnosed COPD). We found that physical activity was positively associated with pulmonary function: FEV1 (regression coefficient 0.40 (95% CI 0.09,0.71)) and FVC (regression coefficient 0.34 (95% CI 0.06,0.61)). Physical activity was associated with anxiety (regression coefficient =0.9 (95% CI 0.3,1.6)) only for physician-diagnosed patients. Lung function and anxiety level determine level of physical activity among COPD patients with mild or moderate airflow obstruction. Thus, integrating it into the physical activity plans could help to increase physical activity level of the patients.


  • Open Access

    eHealth Program to Reduce Hospitalizations Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Study

    by Amanda R van Buul, Caroline Derksen, Ouke Hoedemaker, Oscar van Dijk, Niels H Chavannes, Marise J Kasteleyn

    Background: Hospitalization for acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. eHealth interventions might improve outcomes and decrease costs. Objective: This study aimed to evaluate the effect of an eHealth program on COPD hospitalizations and exacerbations. Methods: This was a real-world study conducted from April 2018 to December 2019 in the Bravis Hospital, the Netherlands. An eHealth program (EmmaCOPD) was offered to COPD patients at risk of exacerbations. EmmaCOPD consisted of an app that used questionnaires (to monitor symptoms) and a step counter (to monitor the number of steps) to detect exacerbations. Patients and their buddies received feedback when their symptoms worsened or the number of steps declined. Generalized estimating equations were used to compare the number of days admitted to the hospital and the total number of exacerbations 12 months before and (max) 18 months after the start of EmmaCOPD. We additionally adjusted for the potential confounders of age, sex, COPD severity, and inhaled corticosteroid use. Results: The 29 included patients had a mean forced expiratory volume in 1 second of 45.5 (SD 17.7) %predicted. In the year before the intervention, the median total number of exacerbations was 2.0 (IQR 2.0-3.0). The median number of hospitalized days was 8.0 days (IQR 6.0-16.5 days). Afterwards, there was a median 1.0 (IQR 0.0-2.0) exacerbation and 2.0 days (IQR 0.0-4.0 days) of hospitalization. After initiation of EmmaCOPD, both the number of hospitalized days and total number of exacerbations decreased significantly (incidence rate ratio 0.209, 95% CI 0.116-0.382; incidence rate ratio 0.310, 95% CI 0.219-0.438). Adjustment for confounders did not affect the results. Conclusions: The eHealth program seems to reduce the number of total exacerbations and number of days of hospitalization due to exacerbations of COPD.


  • Open Access

    eHealth Program to Reduce Hospitalizations Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Retrospective Study (Preprint)

    by Amanda R van Buul, Caroline Derksen, Ouke Hoedemaker, Oscar van Dijk, Niels H Chavannes, Marise J Kasteleyn

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Hospitalization for acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. eHealth interventions might improve outcomes and decrease costs. Objective: This study aimed to evaluate the effect of an eHealth program on COPD hospitalizations and exacerbations. Methods: This was a real-world study conducted from April 2018 to December 2019 in the Bravis Hospital, the Netherlands. An eHealth program (EmmaCOPD) was offered to COPD patients at risk of exacerbations. EmmaCOPD consisted of an app that used questionnaires (to monitor symptoms) and a step counter (to monitor the number of steps) to detect exacerbations. Patients and their buddies received feedback when their symptoms worsened or the number of steps declined. Generalized estimating equations were used to compare the number of days admitted to the hospital and the total number of exacerbations 12 months before and (max) 18 months after the start of EmmaCOPD. We additionally adjusted for the potential confounders of age, sex, COPD severity, and inhaled corticosteroid use. Results: The 29 included patients had a mean forced expiratory volume in 1 second of 45.5 (SD 17.7) %predicted. In the year before the intervention, the median total number of exacerbations was 2.0 (IQR 2.0-3.0). The median number of hospitalized days was 8.0 days (IQR 6.0-16.5 days). Afterwards, there was a median 1.0 (IQR 0.0-2.0) exacerbation and 2.0 days (IQR 0.0-4.0 days) of hospitalization. After initiation of EmmaCOPD, both the number of hospitalized days and total number of exacerbations decreased significantly (incidence rate ratio 0.209, 95% CI 0.116-0.382; incidence rate ratio 0.310, 95% CI 0.219-0.438). Adjustment for confounders did not affect the results. Conclusions: The eHealth program seems to reduce the number of total exacerbations and number of days of hospitalization due to exacerbations of COPD.

  • An eHealth program to reduce hospitalizations due to acute exacerbation of chronic obstructive pulmonary disease – a real-life study

    by Amanda Van Buul, Rini Voeten, Caroline Derksen-Franken, Niels Chavannes, Marise Kasteleyn

    Introduction: Hospitalization for acute exacerbation chronic obstructive pulmonary disease (COPD) is associated with poor prognosis. eHealth interventions might improve outcomes and decrease costs. This study aimed to evaluate the effect of an eHealth program on COPD exacerbations and hospitalizations. Methods: This was a real-life study from April 2018-December 2019 in the Bravis Hospital, the Netherlands. An eHealth program (EmmaCOPD), was offered to COPD patients at risk of exacerbations. EmmaCOPD consisted of a questionnaire application and physical activity coaching companion, aiming to recognize signs of an exacerbation. Patients and their informal caregivers received feedback if symptoms worsened or physical activity declined. Generalized Estimating Equations were used to compare the number of days admitted to the hospital and the number of severe exacerbations 12 months before and 12 months after the start of EmmaCOPD. Results: 29 patients were included, with a mean±SD forced expiratory volume in 1 second of 44.6±16.9 %predicted. In the year before the intervention, mean±SD number of severe exacerbations was 2.5±1.3. The mean±SD number of hospitalization days was 13.1±10.5. Afterward, it was 0.8±0.9 and 3.4±4.5 respectively. Preliminary results showed that after initiation of EmmaCOPD, both the number of severe exacerbations and the total number of hospitalization days significantly decreased (exp(B) 0.26 (95% CI: 0.16-0.41) and 0.21 (95% CI: 0.12-0.38)). Conclusion: The eHealth program seems to reduce the number of severe exacerbations and the number of days of hospitalization due to exacerbation COPD.


  • A systematic diagnostic evaluation combined with an internet-based support system for asthma/COPD

    by Amanda R. van Buul, Thomas S. Wildschut, Tobias N. Bonten, Marise J. Kasteleyn, Annelies M. Slats, Niels H. Chavannes, Christian Taube

    Introduction: Care pathways have many advantages. However, a systematic approach to evaluate asthma/COPD patients referred to secondary care is lacking. Aim: A novel approach that included a systematic diagnostic evaluation combined with an internet-based support system was tested in clinical practice. Methods: Retrospective analyses of patients with asthma/COPD evaluated with a systematic approach or who received usual care were performed, using data from the electronic record system of the Leiden University Medical Center. Diagnostic tests, final diagnosis, lifestyle advices, symptoms, individual care plans, patients and time to referral back to primary care were evaluated and compared between the systematic approach and usual care using t-tests and chi-squared tests. Results: 125 patients were included in the analysis of who 22 had been evaluated with the systematic approach. Mean (±SD) number of diagnostic tests was higher in the systematic approach compared with usual care (7.6±1.0 vs 5.5±1.8, P<0.01). More lifestyle advices (81.8% vs 29.1%), symptom scores (95.5% vs 21.4%) and individual care plans (50.0% vs 7.8%) were recorded (all P<0.01), and more patients were referred back to primary care in the systematic approach (81.8% vs 56.3%, P=0.03). There were no differences in final diagnoses and time to referral back. Conclusion: Our study suggests that a systematic approach stimulates physicians to record lifestyle advices, symptoms and individual care plans. Pulmonologists might believe that the care plans will support the general practitioner and patients in the continuation of care and this could have led in an increase of number of patients referred back to primary care.

  • Peripheral blood gene expression in COPD patients with morning symptoms

    by Amanda R. van Buul, Marise J. Kasteleyn, Suzanne Van Veen, Tom H.M. Ottenhoff, Pieter S. Hiemstra, Marielle C. Haks, Niels H. Chavannes, Christian Taube

    Introduction: Morning symptoms are common in chronic obstructive pulmonary disease (COPD). The aetiology of morning symptoms is unknown. Low-grade systemic inflammation is a feature of COPD. Aim: We hypothesized that morning symptoms are mediated by systemic inflammation. Our aim was to assess the expression of pro-/anti-inflammatory genes in patient with low and high morning symptoms. Methods: In this cross-sectional study, morning symptoms were evaluated with the PRO-Morning COPD Symptoms Questionnaire (range 0-60) in moderate to very severe COPD patients. The median was used to define low and high morning symptoms. The expression of 144 gene transcripts of pro-/anti-inflammatory genes was measured with dual colour reverse-transcriptase multiplex ligation-dependent probe amplification assays on peripheral blood. Mann-Whitney U tests were used to assess differences between the two groups. An Ingenuity pathway analysis (IPA) was used to identify the relation between genes. Results: Eighty patients were included. The mean(±SD) forced expiratory volume in 1 second was 55±17% predicted. The median morning symptom score was 17.0. There was an lower expression of GNLY and an higher expression of IL-15, PTPRCv2, CXCL10,IL-13and FCGR1Ain patients with high morning symptom scores vs. low scores. The IPA showed that these genes are centred around pro-inflammatory TNF-α. No differences were found in the expression of other gene transcripts. Conclusion: There is much overlap in gene expression patterns between COPD patients with high and low morning symptom scores. The results suggest that pro-inflammatory inflammation is associated with high morning symptom scores. TNF-α may serve as a central regulator in this process.

  • Open Access

    A systematic diagnostic evaluation combined with an internet-based self-management support system for patients with asthma or COPD

    by Amanda R van Buul, Thomas S Wildschut, Tobias N Bonten, Marise J Kasteleyn, Annelies M Slats, Niels H Chavannes, Christian Taube

    A systematic diagnostic evaluation combined with an internet-based self-management support system for patients with asthma or COPD Amanda R van Buul,1 Thomas S Wildschut,1,2 Tobias N Bonten,1,2 Marise J Kasteleyn,1,2 Annelies M Slats,1 Niels H Chavannes,2 Christian Taube1,3 1Department of Pulmonology, Leiden University Medical Center, Leiden, the Netherlands; 2Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands; 3Department of Pulmonary Medicine, West German Lung Center, Essen University Hospital, Ruhrlandklinik, University Duisburg-Essen, Essen, Germany Introduction: An (inter)national systematic approach for patients with asthma COPD referred to secondary care is lacking. Therefore, a novel systematic approach was designed and tested in clinical practice. Methods: This was a retrospective observational study of data from the electronic record system of the Leiden University Medical Center. Asthma and COPD patients were included if they were evaluated with a novel systematic approach or if they had a new record for asthma or COPD and received usual care. The novel systematic approach consisted of a predefined diagnostic evaluation combined with an optional internet-based self-management support system. Diagnostic tests, final diagnosis, lifestyle advices, symptoms and individual care plans in the electronic records, number of patients referred back to primary care, and time to referral back to primary care were compared between the systematic approach and usual care groups using t-tests and chi-squared tests. Results: A total of 125 patients were included, of which 22 (21.4%) were evaluated with the systematic approach. Mean (±SD) age was 48.8 (±18.4) years and 59.2% were women. Mean (±SD) number of diagnostic tests was higher in the systematic approach group compared with the usual care group (7.6±1.0 vs 5.5±1.8, P


  • Open Access

    Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms

    by Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes, Christian Taube

    Patients with chronic obstructive pulmonary disease (COPD) experience symptoms that vary over the day. Symptoms at the start of the day might influence physical activity during the rest of the day. Therefore, physical activity during the course of the day was studied in patients with low and high morning symptom scores. This cross-sectional observational study included patients with moderate to very severe COPD. Morning symptoms were evaluated with the PRO-morning COPD Symptoms Questionnaire (range 0–60); the median score was used to create two groups (low and high morning symptom scores). Physical activity was examined with an accelerometer. Activity parameters during the night, morning, afternoon and evening were compared between patients with low and high morning symptom scores using independent t-tests or Mann-Whitney U tests. Seventy nine patients were included. Patients were aged (mean ± SD) 65.6 ± 8.8 years with a mean forced expiratory volume in 1 s of 55 ± 17%predicted. Patients with low morning symptom scores (score < 17.0) took more steps in the afternoon (p = 0.015) and morning (p = 0.030). There were no significant differences during the evening and night. Patients with high morning symptom scores took significantly fewer steps in the morning and afternoon than those with low morning symptom scores. Prospective studies are needed to prove causality between morning symptoms and physical activity during different parts of the day.


  • Open Access

    The association between objectively measured physical activity and morning symptoms in COPD

    by Amanda R van Buul, Marise J Kasteleyn, Niels H Chavannes, Christian Taube

    Purpose: The morning is the most bothersome period for COPD patients. Morning symptom severities in different Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages are not well studied. Furthermore, factors that are associated with morning symptoms, especially the associations with objectively measured physical activity, are also not well described. Materials and methods: The aim of this cross-sectional observational study was to assess morning symptom severity in GOLD A, B, C and D patients, according to the definitions of the GOLD 2015 statement. Morning symptoms were assessed with the PRO-Morning COPD Symptoms Questionnaire. Differences in morning symptom severity between different COPD stages were assessed with a one-way analysis of variance followed by post hoc analyses. The association between dyspnea severity (assessed with the modified Medical Research Council scale), health status, airflow limitation, lung hyperinflation, anxiety and depression, inflammatory parameters, exacerbations, objectively measured physical activity parameters retrieved from accelerometry and morning symptom severity was evaluated using linear regression analysis. Results: Eighty patients were included (aged 65.6±8.7 years, forced expiratory volume in 1 second [FEV1] % predicted 55.1±16.9). Mean (±SD) morning symptom score was 19.7 (±11.7). Morning symptom severity was significantly different between COPD stages: mean (±SD) score in GOLD A was 9.7 (±7.2), in GOLD B 19.8 (±10.7), in GOLD C 8.6 (±9.3) and in GOLD D 23.8 (±11.2) (pp1 (p=0.03) were associated with an increased morning symptom severity. Conclusion: Patients with overall more symptomatic COPD have significant higher morning symptom scores. Morning symptom severity was associated with important clinical outcomes: lower health status, more symptoms, increased anxiety and depression, fewer steps a day, less time in moderate and vigorous physical activity with bouts of at least 10 minutes and lower FEV1. The data suggest that morning symptoms should be carefully assessed in addition to assessment by general COPD-specific questionnaires, especially in those with more symptomatic COPD. More research is needed on potential therapies to improve morning symptoms; this study shows potential targets for intervention.


  • Open Access

    Morning symptoms in COPD: a treatable yet often overlooked factor

    by Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes, Christian Taube

    Introduction: Chronic obstructive pulmonary disease (COPD) patients experience the morning as the worst period of the day. Nevertheless, morning symptoms are not mentioned in COPD guidelines. Areas covered: Different topics on morning symptoms are covered in this review to underline their importance: occurrence, tools for assessment and therapies to limit morning symptoms. Expert commentary: Morning symptoms are common and have a negative influence on a patient’s life. Pharmacotherapy seems to be effective in decreasing morning symptoms. A validated tool to assess morning symptoms is lacking. Therefore, more research should focus on assessing morning symptoms with a validated tool to further prove the effect of (pharmaco-) therapy. This will hopefully result in inclusion of morning symptoms in future guidelines.